MarketCap
Facebook
X
Telegram
Trean Insurance Group Current Ratio | TIG
Annual Current Ratio Trean Insurance Group
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.25 | 1.39 | 1.43 | 1.19 | 1.15 | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.43 | 1.15 | 1.28 |
Quarterly Current Ratio Trean Insurance Group
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 1.34 | 1.37 | 1.39 | 1.39 | 1.41 | 1.42 | 1.44 | 1.43 | 1.42 | 1.43 | 1.43 | 1.19 | 1.19 | 1.19 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.44 | 1.19 | 1.36 |
Current Ratio of other stocks in the Biotechnology industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Praxis Precision Medicines
PRAX
|
15.7 | $ 277.94 | 5.85 % | $ 6.25 B |  USA |
 |
Prelude Therapeutics Incorporated
PRLD
|
1.94 | $ 3.59 | 0.98 % | $ 276 M | USA |
 |
ProQR Therapeutics N.V.
PRQR
|
1.78 | $ 1.36 | 1.88 % | $ 143 M |  Niderland |
 |
Ocular Therapeutix
OCUL
|
5.26 | $ 6.61 | 2.8 % | $ 1.24 B | USA |
 |
PolyPid Ltd.
PYPD
|
24.7 | $ 6.08 | 7.23 % | $ 99.4 M |  Israel |
 |
Outlook Therapeutics
OTLK
|
0.366 | $ 0.44 | -0.93 % | $ 15.3 M | USA |
 |
uniQure N.V.
QURE
|
1.32 | $ 21.68 | 3.19 % | $ 1.25 B | Niderland |
 |
Ultragenyx Pharmaceutical
RARE
|
0.955 | $ 15.48 | -0.58 % | $ 1.53 B | USA |
 |
Rafael Holdings
RFL
|
7.49 | $ 1.02 | -4.67 % | $ 52.4 M | USA |
 |
REGENXBIO
RGNX
|
1.29 | $ 7.62 | 3.25 % | $ 393 M | USA |
 |
Rigel Pharmaceuticals
RIGL
|
4.21 | $ 39.52 | -13.54 % | $ 711 M | USA |
 |
Celsion Corporation
CLSN
|
2.35 | - | -6.63 % | $ 13.9 M | USA |
 |
I-Mab
IMAB
|
2.92 | - | - | $ 866 M |  China |
 |
Tenax Therapeutics
TENX
|
14.6 | $ 1.68 | 3.07 % | $ 65.9 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
0.922 | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
1.34 | - | -13.47 % | $ 169 M | France |
 |
Scholar Rock Holding Corporation
SRRK
|
2.55 | $ 46.77 | 2.78 % | $ 5.36 B | USA |
 |
CureVac N.V.
CVAC
|
7.56 | - | - | $ 867 M |  Germany |
 |
Spero Therapeutics
SPRO
|
6.96 | $ 1.03 | 1.47 % | $ 57.7 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
0.796 | - | 0.74 % | $ 768 M | Israel |
 |
Abcam plc
ABCM
|
3.2 | - | - | $ 4.9 B |  Britain |
 |
Rezolute
RZLT
|
9.28 | $ 3.85 | 5.77 % | $ 400 M | USA |
 |
Midatech Pharma plc
MTP
|
2.68 | - | -18.52 % | $ 27.3 M | Britain |
 |
Tiziana Life Sciences PLC
TLSA
|
1.54 | $ 0.69 | 11.43 % | $ 73.6 M | Britain |
 |
MorphoSys AG
MOR
|
1.02 | - | 2.43 % | $ 254 M | Germany |
 |
Affimed N.V.
AFMD
|
1.69 | - | -34.95 % | $ 21.5 M | Germany |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
0.811 | - | -1.58 % | $ 28.1 M | China |
 |
Celyad Oncology SA
CYAD
|
1.88 | - | - | $ 12.5 M |  Belgium |
 |
Seer
SEER
|
8.05 | $ 1.63 | 0.18 % | $ 90.4 M | USA |
 |
Gracell Biotechnologies
GRCL
|
5.9 | - | - | $ 3.37 B | China |
 |
Stoke Therapeutics
STOK
|
6.34 | $ 26.51 | 1.69 % | $ 1.57 B | USA |
 |
Sutro Biopharma
STRO
|
0.568 | $ 9.57 | 4.08 % | $ 81.3 M | USA |
|
Silence Therapeutics plc
SLN
|
1.12 | $ 19.73 | 0.03 % | $ 2.8 B | Britain |
 |
Taysha Gene Therapies
TSHA
|
3.56 | $ 4.34 | 6.11 % | $ 1.39 B | USA |
 |
Soligenix
SNGX
|
2.34 | $ 0.34 | 0.54 % | $ 1.76 M | USA |
 |
Spruce Biosciences
SPRB
|
5.05 | $ 46.46 | 8.78 % | $ 35.6 M | USA |
 |
Supernus Pharmaceuticals
SUPN
|
3.72 | $ 26.14 | -2.24 % | $ 1.48 B | USA |
 |
Galapagos NV
GLPG
|
20 | - | - | $ 1.83 B | Belgium |
 |
Savara
SVRA
|
5.04 | $ 4.82 | 9.93 % | $ 1.07 B | USA |
 |
Viking Therapeutics
VKTX
|
9.34 | $ 26.86 | 4.15 % | $ 3.03 B | USA |
 |
Teligent, Inc.
TLGT
|
1.92 | - | -13.85 % | $ 16.1 M | USA |
 |
Viela Bio, Inc.
VIE
|
8.45 | - | - | $ 2.91 B | USA |
 |
TG Therapeutics
TGTX
|
2.56 | $ 59.78 | 3.1 % | $ 8.63 B | USA |
 |
Aphria Inc.
APHA
|
5.3 | - | -0.45 % | $ 4.87 B |  Canada |
 |
Aerpio Pharmaceuticals, Inc.
ARPO
|
24 | - | -0.90 % | $ 104 M | USA |
 |
Chiasma, Inc.
CHMA
|
9.17 | - | -6.00 % | $ 238 M | USA |
 |
Wave Life Sciences Ltd.
WVE
|
5.69 | $ 3.37 | 4.66 % | $ 568 M |  Singapore |
 |
Adamas Pharmaceuticals, Inc.
ADMS
|
3.2 | - | - | $ 376 M | USA |